Cargando…
Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2)
BACKGROUND: Bothropstoxin-I (BthTx-I) is a Lys49-phospholipase A(2) (Lys49-PLA(2)) from the venom of Bothrops jararacussu, which despite of the lack of catalytic activity induces myotoxicity, inflammation and pain. The C-terminal region of the Lys49-PLA(2)s is important for these effects; however, t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303236/ https://www.ncbi.nlm.nih.gov/pubmed/28203248 http://dx.doi.org/10.1186/s40409-017-0099-6 |
_version_ | 1782506671181922304 |
---|---|
author | Zambelli, Vanessa Olzon Chioato, Lucimara Gutierrez, Vanessa Pacciari Ward, Richard John Cury, Yara |
author_facet | Zambelli, Vanessa Olzon Chioato, Lucimara Gutierrez, Vanessa Pacciari Ward, Richard John Cury, Yara |
author_sort | Zambelli, Vanessa Olzon |
collection | PubMed |
description | BACKGROUND: Bothropstoxin-I (BthTx-I) is a Lys49-phospholipase A(2) (Lys49-PLA(2)) from the venom of Bothrops jararacussu, which despite of the lack of catalytic activity induces myotoxicity, inflammation and pain. The C-terminal region of the Lys49-PLA(2)s is important for these effects; however, the amino acid residues that determine hyperalgesia and edema are unknown. The aim of this study was to characterize the structural determinants for the Lys49-PLA(2)-induced nociception and inflammation. METHODS: Scanning alanine mutagenesis in the active-site and C-terminal regions of BthTx-I has been used to study the structural determinants of toxin activities. The R118A mutant was employed as this substitution decreases PLA(2) myotoxicity. In addition, K115A and K116A mutants – which contribute to decrease cytotoxicity – and the K122A mutant – which decreases both myotoxicity and cytotoxicity – were also used. The H48Q mutant – which does not interfere with membrane damage or myotoxic activity – was used to evaluate if the PLA(2) catalytic site is relevant for the non-catalytic PLA(2)-induced pain and inflammation. Wistar male rats received intraplantar injections with mutant PLA(2). Subsequently, hyperalgesia and edema were evaluated by the paw pressure test and by a plethysmometer. Native and recombinant BthTx-I were used as controls. RESULTS: Native and recombinant BthTx-I induced hyperalgesia and edema, which peaked at 2 h. The R118A mutant did not induce nociception or edema. The mutations K115A and K116A abolished hyperalgesia without interfering with edema. Finally, the K122A mutant did not induce hyperalgesia and presented a decreased inflammatory response. CONCLUSIONS: The results obtained with the BthTx-I mutants suggest, for the first time, that there are distinct residues responsible for the hyperalgesia and edema induced by BthTx-I. In addition, we also showed that cytolytic activity is essential for the hyperalgesic effect but not for edematogenic activity, corroborating previous data showing that edema and hyperalgesia can occur in a non-dependent manner. Understanding the structure-activity relationship in BthTx-I has opened new possibilities to discover the target for PLA(2)-induced pain. |
format | Online Article Text |
id | pubmed-5303236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53032362017-02-15 Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2) Zambelli, Vanessa Olzon Chioato, Lucimara Gutierrez, Vanessa Pacciari Ward, Richard John Cury, Yara J Venom Anim Toxins Incl Trop Dis Research BACKGROUND: Bothropstoxin-I (BthTx-I) is a Lys49-phospholipase A(2) (Lys49-PLA(2)) from the venom of Bothrops jararacussu, which despite of the lack of catalytic activity induces myotoxicity, inflammation and pain. The C-terminal region of the Lys49-PLA(2)s is important for these effects; however, the amino acid residues that determine hyperalgesia and edema are unknown. The aim of this study was to characterize the structural determinants for the Lys49-PLA(2)-induced nociception and inflammation. METHODS: Scanning alanine mutagenesis in the active-site and C-terminal regions of BthTx-I has been used to study the structural determinants of toxin activities. The R118A mutant was employed as this substitution decreases PLA(2) myotoxicity. In addition, K115A and K116A mutants – which contribute to decrease cytotoxicity – and the K122A mutant – which decreases both myotoxicity and cytotoxicity – were also used. The H48Q mutant – which does not interfere with membrane damage or myotoxic activity – was used to evaluate if the PLA(2) catalytic site is relevant for the non-catalytic PLA(2)-induced pain and inflammation. Wistar male rats received intraplantar injections with mutant PLA(2). Subsequently, hyperalgesia and edema were evaluated by the paw pressure test and by a plethysmometer. Native and recombinant BthTx-I were used as controls. RESULTS: Native and recombinant BthTx-I induced hyperalgesia and edema, which peaked at 2 h. The R118A mutant did not induce nociception or edema. The mutations K115A and K116A abolished hyperalgesia without interfering with edema. Finally, the K122A mutant did not induce hyperalgesia and presented a decreased inflammatory response. CONCLUSIONS: The results obtained with the BthTx-I mutants suggest, for the first time, that there are distinct residues responsible for the hyperalgesia and edema induced by BthTx-I. In addition, we also showed that cytolytic activity is essential for the hyperalgesic effect but not for edematogenic activity, corroborating previous data showing that edema and hyperalgesia can occur in a non-dependent manner. Understanding the structure-activity relationship in BthTx-I has opened new possibilities to discover the target for PLA(2)-induced pain. BioMed Central 2017-02-10 /pmc/articles/PMC5303236/ /pubmed/28203248 http://dx.doi.org/10.1186/s40409-017-0099-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zambelli, Vanessa Olzon Chioato, Lucimara Gutierrez, Vanessa Pacciari Ward, Richard John Cury, Yara Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2) |
title | Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2) |
title_full | Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2) |
title_fullStr | Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2) |
title_full_unstemmed | Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2) |
title_short | Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A(2) |
title_sort | structural determinants of the hyperalgesic activity of myotoxic lys49-phospholipase a(2) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303236/ https://www.ncbi.nlm.nih.gov/pubmed/28203248 http://dx.doi.org/10.1186/s40409-017-0099-6 |
work_keys_str_mv | AT zambellivanessaolzon structuraldeterminantsofthehyperalgesicactivityofmyotoxiclys49phospholipasea2 AT chioatolucimara structuraldeterminantsofthehyperalgesicactivityofmyotoxiclys49phospholipasea2 AT gutierrezvanessapacciari structuraldeterminantsofthehyperalgesicactivityofmyotoxiclys49phospholipasea2 AT wardrichardjohn structuraldeterminantsofthehyperalgesicactivityofmyotoxiclys49phospholipasea2 AT curyyara structuraldeterminantsofthehyperalgesicactivityofmyotoxiclys49phospholipasea2 |